Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT01036399Phase 2Terminated
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Nov 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in peripheral T-cell lymphoma (PTCL), sponsored by Alma Mater Studiorum – Università di Bologna. Started Nov 2008; status: terminated.
02
Drugs
lenalidomide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01036399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01036399.